Regeneron Pharmaceuticals, Inc. (REGN)
-NasdaqGS 316.63 
3.76(1.20%) Oct 1, 4:00PM EDT|After Hours
:
312.87 3.76 (1.19%) Oct 1, 6:20PM EDT
| Prev Close: | 312.87 |
|---|
| Open: | 316.58 |
|---|
| Bid: | 210.01 x 200 |
|---|
| Ask: | 317.48 x 100 |
|---|
| 1y Target Est: | 303.75 |
|---|
| Beta: | 0.93 |
|---|
| Next Earnings Date: | 21-Oct-13 |
|---|
| Day's Range: | 307.65 - 319.50 |
|---|
| 52wk Range: | 136.13 - 319.83 |
|---|
| Volume: | 729,866 |
|---|
| Avg Vol (3m): | 693,842 |
|---|
| Market Cap: | 30.93B |
|---|
| P/E (ttm): | 41.87 |
|---|
| EPS (ttm): | 7.56 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Featured on Yahoo! Finance
Headlines
- [video] Cramer's lessons from the 1000th episodeat CNBC(Tue, Oct 1)
- Cramer: Market opportunities haven't vanishedat CNBC(Tue, Oct 1)
- Analysts: Microsoft May Show Lower Margins and 3 Other Research Notes to Peruseat Wall St. Cheat Sheet(Tue, Oct 1)
- [video] Jim Cramer Quick Take: 2,000 'Mad Money' Episodesat TheStreet(Tue, Oct 1)
- [video] Cramer's 2000th Mad Money Episodeat TheStreet(Mon, Sep 30)
- Today's 3 Best Stocks in the S&P 500at Motley Fool(Mon, Sep 30)
- LDK Solar and Panera are big market moversAP(Mon, Sep 30)
- LDK Solar and Intel are big market moversAP(Mon, Sep 30)
- More Important Than "Shots on Goal"at Motley Fool(Mon, Sep 30)
- Device firms, Regeneron see gains while general markets fear shutdownat MarketWatch(Mon, Sep 30)
- Analysts: Walgreens May Beat Earnings Expectations and 3 Other Research Notes to Exploreat Wall St. Cheat Sheet(Mon, Sep 30)
- Regeneron Jumps 4% as Analysts See Drug Potentialat Barrons.com(Mon, Sep 30)
- Biotech Investments? Get A Second Opinionat Seeking Alpha(Mon, Sep 30)
- J.C. Penney sinks to lowest since 1929 crashMarketWatch(Mon, Sep 30)
- Huntsman Corporation Division President Sells 75K Shares and 4 Insider Sales to Noteat Wall St. Cheat Sheet(Mon, Sep 30)
Key Statistics
| Forward P/E (1 yr): | 57.99 |
|---|
| P/S (ttm): | 17.57 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 3.45 |
|---|
| Quarterly EPS Est
(Sep-13)
: | 0.89 |
|---|
| Mean Recommendation*: | 2.0 |
|---|
| PEG Ratio (5 yr expected): | 3.68 |
|---|
Business Summary
Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions in the United States and internationally.
View More